Avatrombopag

Avatrombopag
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T7417-1mg 1 mg

7 - 10 business days*

60.00€
TGM-T7417-2mg 2 mg

7 - 10 business days*

83.00€
TGM-T7417-5mg 5 mg

7 - 10 business days*

122.00€
TGM-T7417-10mg 10 mg

7 - 10 business days*

195.00€
TGM-T7417-25mg 25 mg

7 - 10 business days*

355.00€
TGM-T7417-50mg 50 mg

7 - 10 business days*

596.00€
TGM-T7417-100mg 100 mg

7 - 10 business days*

850.00€
TGM-T7417-500mg 500 mg

7 - 10 business days*

1,731.00€
 
Description: Avatrombopag (YM477) is a new oral thrombopoietin (TPO) receptor agonist, activating... more
Product information "Avatrombopag"
Description: Avatrombopag (YM477) is a new oral thrombopoietin (TPO) receptor agonist, activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platelet production. Target: Thrombin, Thrombopoietin Receptor. Smiles: OC(=O)C1CCN(CC1)c1ncc(cc1Cl)C(=O)Nc1nc(-c2cc(Cl)cs2)c(s1)N1CCN(CC1)C1CCCCC1. References: Xu H, Cai R.Avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease.Expert Rev Clin Pharmacol. 2019 Sep,12(9):859-865
Keywords: E5501, YM477, AKR-501
Supplier: TargetMol
Supplier-Nr: T7417

Properties

Application: Targets thrombopoietin receptor (TPOR, MPL, CD110)
MW: 649.65 D
Formula: C29H34Cl2N6O3S2

Database Information

CAS : 570406-98-3| Matching products
KEGG ID : K05082 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Avatrombopag"
Write a review
or to review a product.
Viewed